Clinical Trials Logo

Hyperprolactinaemia clinical trials

View clinical trials related to Hyperprolactinaemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT01852331 Completed - Schizophrenia Clinical Trials

Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

PGD-RCT
Start date: January 2013
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that Peony-Glycyrrhiza Decoction (PGD) adjunctive therapy could reduce the incidence of prolactin (PRL)-related adverse events in patients with schizophrenia and suppress antipsychotic-induced elevation of PRL levels. This is a placebo-controlled trial conducted in schizophrenic patients to determine whether PGD adjunctive treatment could produce greater biochemical and clinical improvement on hyperprolactinemia (hyperPRL) compared to placebo treatment.